ONWARD programa webcast para proporcionar una actualización comercial de medio año 2023
September 05, 2023 20:23 ET
|
ONWARD Medical
Eindhoven, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), la compañía de tecnología médica que crea terapias innovadoras para restaurar el movimiento, la función y la...
Webcast ONWARD pianifica per fornire un aggiornamento aziendale semestrale 2023
September 05, 2023 20:23 ET
|
ONWARD Medical
Eindhoven, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), la società di tecnologia medica che crea terapie innovative per ripristinare il movimento, la funzione e...
ONWARD Schedules Webcast to Provide Half Year 2023 Business Update
September 05, 2023 20:23 ET
|
ONWARD Medical
Eindhoven, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in...
Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights
September 04, 2023 16:00 ET
|
Celyad Oncology SA
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement commitments from historical shareholdersEncouraging...
BioCorRx Reports Business Update for the Second Quarter of 2023
August 14, 2023 16:34 ET
|
BioCorRx Inc
On Track to Meet 2023 Regulatory Milestones ANAHEIM, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...
Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
August 14, 2023 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
BiondVax Reports Second Quarter Financial Results and Provides Business Update
August 11, 2023 09:00 ET
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- via IBN - BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative...
IMUNON Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023 08:00 ET
|
Imunon, Inc.
Advances Non-Viral DNA-Mediated Immunotherapy and Next-Generation Vaccine Programs with Multiple Near-Term Milestones Supported by a Strong Balance Sheet Conference Call Begins Today at...
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
GeoJunxion NV (ticker: GOJXN.AS) - Business Update Full Year 2022-2023
July 27, 2023 02:00 ET
|
GeoJunxion N.V.
GeoJunxion NV (ticker: GOJXN.AS) Business Update Full Year 2022-2023 Key Facts: 42% revenue growth for the FY 2022/’23 compared to the same period in 2021/22;Net Operational Expenses...